List of works - Pasqua Oreste

Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists

scientific article

Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery.

scientific article

Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives

scientific article published on January 2003

Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists

scientific article published in June 2004

Further Purification of Heparin Reduces Its Bleeding Effects in the Mesenteric Vessels of Rats

scientific article

Generation of "neoheparin" from E. coli K5 capsular polysaccharide.

scientific article

Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.

scientific article published on 15 September 2011

Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.

scientific article

Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues

scientific article published on 03 August 2016

Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide

scientific article

Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists

scientific article published on 19 November 2012

Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist

scientific article published on 11 May 2016

Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III.

scientific article

Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus.

scientific article published on 4 February 2008

Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides

scientific article published on 14 May 2009

Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus

scientific article published on 16 August 2010

The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms

scientific article

Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy

scientific article published on 18 February 2015

List of works by Pasqua Oreste

Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists

Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery.

Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives

Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists

Further Purification of Heparin Reduces Its Bleeding Effects in the Mesenteric Vessels of Rats

Generation of "neoheparin" from E. coli K5 capsular polysaccharide.

Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.

Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.

Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues

Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide

Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists

Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist

Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III.

Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus.

Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides

Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus

The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms

Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy